Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

  • Read more about Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

The palatability and tolerability of deferasirox taken with different beverages or foods.

  • Read more about The palatability and tolerability of deferasirox taken with different beverages or foods.

Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

  • Read more about Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

Infections in hospitalized children and young adults with acute leukemia in Morocco.

  • Read more about Infections in hospitalized children and young adults with acute leukemia in Morocco.

Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

  • Read more about Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.

  • Read more about Children's Oncology Group's 2013 blueprint for research: stem cell transplantation.

131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.

  • Read more about 131I-MIBG followed by consolidation with busulfan, melphalan and autologous stem cell transplantation for refractory neuroblastoma.

Clinical features and outcomes in patients with secondary Ewing sarcoma.

  • Read more about Clinical features and outcomes in patients with secondary Ewing sarcoma.

The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

  • Read more about The significance of serial histopathology in a residual mass for outcome of intermediate risk stage 3 neuroblastoma.

Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

  • Read more about Clinical features and outcomes in patients with Ewing sarcoma and regional lymph node involvement.

Pagination

  • Previous page ‹‹
  • Page 10
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List